Evidence map›Paper›PMID 35386328›Full record

ReviewBioactive materials2022

Advances in spray products for skin regeneration.

Paula Pleguezuelos-Beltrán, Patricia Gálvez-Martín, Daniel Nieto-García, Juan Antonio Marchal, Elena López-Ruiz

Abstract readReview
In one paragraph

Review in Bioactive materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Cell-Laden Supramolecular and Covalent Polymer Hydrogels for High-Shear Delivery: A Design of Experiments Approach.Chemistry of materials : a publication of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Portable Bioprinter in Ischemic Wound Therapy: a Pilot Study.Sovremennye tekhnologii v meditsine · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paula Pleguezuelos-BeltránBiopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Patricia Gálvez-MartínR&D Human Health, Bioibérica S.A.U, Barcelona, Spain.
Daniel Nieto-GarcíaDepartment of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.
Juan Antonio MarchalBiopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, Granada, Spain.
Elena López-RuizBiopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, skin wounds are still an issue for healthcare professionals. Although numerous approaches have been developed over the years for skin regeneration, recent advances in regenerative medicine offer very promising strategies for the fabrication of artificial skin substitutes, including 3D bioprinting, electrospinning or spraying, among others. In particular, skin sprays are an innovative technique still under clinical evaluation that show great potential for the delivery of cells and hydrogels to treat acute and chronic wounds. Skin sprays present significant advantages compared to conventional treatments for wound healing, such as the facility of application, the possibility to treat large wound areas, or the homogeneous distribution of the sprayed material. In this article, we review the latest advances in this technology, giving a detailed description of investigational and currently commercially available acellular and cellular skin spray products, used for a variety of diseases and applying different experimental materials. Moreover, as skin sprays products are subjected to different classifications, we also explain the regulatory pathways for their commercialization and include the main clinical trials for different skin diseases and their treatment conditions. Finally, we argue and suggest possible future trends for the biotechnology of skin sprays for a better use in clinical dermatology.

Indexed as

ATMP, advanced therapy medicinal productBLA, Biologic License ApplicationCAT, Committee for Advances TherapiesCEA, cultured epithelial autograftCFR, Code of Federal RegulationsCHMP, Committee for Medicinal Product for Human UseCTD, Common Technical DocumentDMEM, Dulbecco's Modified Eagle's mediumECM, extracellular matrixEMA, European Medicines AgencyEU, European UnionFDA, Food and Drug AdministrationFibrinGAGs, glycosaminoglycansGLP, Good Laboratory PracticeGMP, Good Manufacturing PracticeHA, hyaluronic acidHCT/Ps, human cells, tissues, and cellular and tissue-based productsHydrogelISO, International Organization for StandardizationMA, marketing authorizationNP, Notified bodyOTAT, Office of Tissues and Advanced TherapiesPCL, polycaprolactonePEG, polyethylene glycolPHSA, Public Health Service ActPMA, Premarket ApprovalPRF, platelet rich fibrinPRP, platelet rich plasmaPU, polyurethaneQMS, Quality Management SystemSkinSprayTE, tissue engineeringTissue engineeringUSA, United States of America

Identifiers

PMID35386328
PMCPMC8965724

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.